Results 201 to 210 of about 70,554 (222)

Cetuximab

Reactions Weekly, 2018
openaire   +2 more sources

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

New England Journal of Medicine, 2004
David Cunningham, Salvatore Siena, Armando Santoro   +2 more
exaly  

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Lancet, The, 2019
Hisham Mehanna, Max Robinson, Andrew Hartley   +2 more
exaly  

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

New England Journal of Medicine, 2008
Ricard Mesia, Fernando Rivera, Ihor O Vynnychenko   +2 more
exaly  

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Lancet, The, 2019
Avraham Eisbruch, Paul M Harari, Erich M Sturgis   +2 more
exaly  

Cetuximab

Reactions Weekly, 2010
openaire   +2 more sources

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Lancet, The, 2009
Robert Pirker, Maciej Krzakowski, Rodryg Adam Ramlau   +2 more
exaly  

Cetuximab dosing by rash—is the scaling of EVEREST meaningful?

Nature Reviews Clinical Oncology, 2012
Sebastian Stintzing
exaly  

Cetuximab

Reactions Weekly, 2003
openaire   +1 more source

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Lancet, The, 2011
Timothy S Maughan, Richard H Wilson, David J Fisher   +2 more
exaly